Impact of Pulmonary microbiota on lung cancer treatment-related pneumonia
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 15 (14) , 4503-4512
Abstract
Background: The use of immunotherapy is progressively expanding for the treatment of lung cancer, either alone or in combination with radiotherapy. However, treatment-related adverse events, especially pneumonia, significantly limit the drug's effectiveness in treating lung cancer. The occurrence of lung cancer, immunotherapy, and pulmonary radiotherapy can all contribute to the imbalance in the pulmonary microbiota, rendering the lungs more susceptible to inflammatory reactions.Keywords
This publication has 50 references indexed in Scilit:
- Fast and sensitive protein alignment using DIAMONDNature Methods, 2014
- STRING v10: protein–protein interaction networks, integrated over the tree of lifeNucleic Acids Research, 2014
- Divergent Functions of Toll-Like Receptors During Bacterial Lung InfectionsAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammationMicrobiome, 2013
- CD-HIT: accelerated for clustering the next-generation sequencing dataBioinformatics, 2012
- IDBA-UD: a de novo assembler for single-cell and metagenomic sequencing data with highly uneven depthBioinformatics, 2012
- Metagenomic biomarker discovery and explanationGenome Biology, 2011
- Ab initio gene identification in metagenomic sequencesNucleic Acids Research, 2010
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Multivariate analyses in microbial ecologyFEMS Microbiology Ecology, 2007